<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="22561">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02813109</url>
  </required_header>
  <id_info>
    <org_study_id>U-BIO-16</org_study_id>
    <nct_id>NCT02813109</nct_id>
  </id_info>
  <brief_title>Urine Biomarkers for Renal Function Monitoring in Preterm Infants</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inha University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hallym University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Inha University Hospital</source>
  <brief_summary>
    <textblock>
      The true renal function of preterm infants is difficult to evaluate. Serum creatinine (Cr)
      levels in infants are unreliable as a detector of renal function in the first few days of
      life because they may continue to reflect maternal levels. Although few candidates appear to
      be a useful biomarker for kidney injury, scant reference data on these biomarker in preterm
      infants exist, and studies have yielded conflicting results. Therefore, we aimed to
      determine the reliable urinary biomarkers to detect kidney injuries in preterm infants.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>correlation of urinary NGAL (neutrophil-gelatinase-associated lipocalin) with serum creatinine</measure>
    <time_frame>postnatal 1day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>correlation of urinary NGAL (neutrophil-gelatinase-associated lipocalin) with serum creatinine</measure>
    <time_frame>postnatal 3day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>correlation of urinary NGAL (neutrophil-gelatinase-associated lipocalin) with serum creatinine</measure>
    <time_frame>postnatal 5day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>correlation of urinary NGAL (neutrophil-gelatinase-associated lipocalin) with serum creatinine</measure>
    <time_frame>postnatal 7day</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Premature Infant</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        below gestational age 37 weeks
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  premature infants born before 37 weeks of gestational age

        Exclusion Criteria:

          -  cardiac or renal anomalies

          -  transferred in 2 days after birth from other hospitals
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Juyoung Lee, MD, PhD</last_name>
    <phone>82-32-890-3506</phone>
    <email>juyounglee@inha.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inha University Hospital</name>
      <address>
        <city>Incheon</city>
        <zip>22332</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yun Nam Kim</last_name>
      <phone>82-32-890-3691</phone>
      <email>ynkim@inhauh.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hallym University Medical Center - Kangnam</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yo Han Ahn, MD</last_name>
      <phone>82-10-2410-5237</phone>
      <email>medicalpooh@hanmail.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <lastchanged_date>June 21, 2016</lastchanged_date>
  <firstreceived_date>June 20, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inha University Hospital</investigator_affiliation>
    <investigator_full_name>Juyoung Lee</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
